{"log_id": 586050279366612116, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0.009921, "average": 0.946084, "min": 0.540455}, "location": {"width": 742, "top": 196, "height": 28, "left": 242}, "words": "损伤可能只有通过穿刺活检才能观到。建议在下述情况下行肝脏活检:1)治疗开始前"}, {"probability": {"variance": 0.012059, "average": 0.93751, "min": 0.575405}, "location": {"width": 741, "top": 228, "height": 27, "left": 243}, "words": "或初次给药后2-4个月内:2)当总累积剂量达到1.5g时:3)每次加量1.0-1.5g后。一旦"}, {"probability": {"variance": 0.016872, "average": 0.95402, "min": 0.357715}, "location": {"width": 741, "top": 260, "height": 25, "left": 243}, "words": "发生中度纤维化或任何程度的便化时须停止用药;如果有轻度肝纤维化则建议6"}, {"probability": {"variance": 0.011698, "average": 0.957704, "min": 0.516564}, "location": {"width": 741, "top": 290, "height": 25, "left": 243}, "words": "个月内重复行一次脏活检在治疗开始之前比较易见轻度的组织学改变如脂肪变性和"}, {"probability": {"variance": 0.020738, "average": 0.930278, "min": 0.476554}, "location": {"width": 729, "top": 322, "height": 25, "left": 244}, "words": "低度肝门静脉炎尽警这些度的改变通常不是避免或停止使用甲氨蝶呤治疗的因素"}, {"probability": {"variance": 0.002732, "average": 0.964785, "min": 0.861555}, "location": {"width": 155, "top": 354, "height": 23, "left": 243}, "words": "但是用药必须谨到"}, {"probability": {"variance": 0.004582, "average": 0.969656, "min": 0.673254}, "location": {"width": 745, "top": 384, "height": 26, "left": 238}, "words": "通常,备接受正在接受甲氨蝶呤治疗的者,推荐以卜的实验室检查作为必要的临"}, {"probability": {"variance": 0.011409, "average": 0.962156, "min": 0.380545}, "location": {"width": 745, "top": 416, "height": 25, "left": 239}, "words": "床评估的一部分和合的监测方法、这些检查包括:全血维胞计数、血细胞比积、尿检"}, {"probability": {"variance": 0.005964, "average": 0.970489, "min": 0.595207}, "location": {"width": 745, "top": 447, "height": 24, "left": 237}, "words": "验、肾功能检查和肝功能检,同样也推荐胸部X线检查应该在治疗前、治疗的适当"}, {"probability": {"variance": 0.013548, "average": 0.938105, "min": 0.481615}, "location": {"width": 744, "top": 476, "height": 29, "left": 239}, "words": "时期和木次治疗后接受上述检查,在起始或改变量时,或在甲氨蝶呤血药浓度升高的"}, {"probability": {"variance": 0.008393, "average": 0.964365, "min": 0.516874}, "location": {"width": 745, "top": 508, "height": 25, "left": 238}, "words": "风险增加时(如脱水),推存给予更频繁的监测。在银屑病治疗期间,推荐监测以下指"}, {"probability": {"variance": 0.004126, "average": 0.977069, "min": 0.61757}, "location": {"width": 742, "top": 539, "height": 26, "left": 239}, "words": "标:每月行血液系统检查,每1-2月行肝肾功能检查,抗肿瘤治疗时一般推荐更频繁的"}, {"probability": {"variance": 0.006586, "average": 0.963489, "min": 0.649681}, "location": {"width": 735, "top": 569, "height": 26, "left": 238}, "words": "监测。当给予火剂量或长期治疗时,行肝脏活检或骨髓穿刺活检是有帮助的或是重要的"}, {"probability": {"variance": 0.005043, "average": 0.974337, "min": 0.586571}, "location": {"width": 744, "top": 601, "height": 27, "left": 239}, "words": "甲氨蝶呤从第三间隙腔内(如胸腔积液或腹水)缓慢排出这会导致末相半衰期的延长"}, {"probability": {"variance": 0.008249, "average": 0.963574, "min": 0.485321}, "location": {"width": 745, "top": 632, "height": 25, "left": 238}, "words": "和不可预知的毒性。如果患者有显著的第三河隙蓄积,可以在治疗前抽出体液并且监测"}, {"probability": {"variance": 0.042745, "average": 0.912583, "min": 0.36637}, "location": {"width": 162, "top": 663, "height": 23, "left": 239}, "words": "甲氨蝶呤血浆浓"}, {"probability": {"variance": 0.007757, "average": 0.943756, "min": 0.791558}, "location": {"width": 79, "top": 724, "height": 23, "left": 207}, "words": "患者须知"}, {"probability": {"variance": 0.016209, "average": 0.951964, "min": 0.411452}, "location": {"width": 740, "top": 753, "height": 26, "left": 243}, "words": "应告知者毒性反应的早期症状和体征,如果症状一发生立即去看医生,以及必要的"}, {"probability": {"variance": 0.016568, "average": 0.948916, "min": 0.494951}, "location": {"width": 436, "top": 785, "height": 24, "left": 206}, "words": "密切随访,包括定期的实验注检作以监测毒性反应"}, {"probability": {"variance": 0.0191, "average": 0.924818, "min": 0.504128}, "location": {"width": 740, "top": 814, "height": 28, "left": 244}, "words": "应告知患者使用甲氨蝶岭后潜在的获益和风险,应该和男性及女性患者讨论接受甲氨蝶"}, {"probability": {"variance": 0.003782, "average": 0.974149, "min": 0.784713}, "location": {"width": 279, "top": 847, "height": 25, "left": 207}, "words": "昤治疗后对生殖能力影响的风险"}, {"probability": {"variance": 0.001082, "average": 0.984713, "min": 0.837698}, "location": {"width": 739, "top": 878, "height": 26, "left": 244}, "words": "因为有光敏反应的可能性,接受甲氨蝶呤治疗的患者应该避免无防护下过度的接受阳光"}, {"probability": {"variance": 3.8e-05, "average": 0.995079, "min": 0.984645}, "location": {"width": 140, "top": 909, "height": 24, "left": 207}, "words": "或太阳灯的照射"}, {"probability": {"variance": 1.7e-05, "average": 0.998012, "min": 0.988016}, "location": {"width": 142, "top": 972, "height": 24, "left": 206}, "words": "感染或免疫状态"}, {"probability": {"variance": 0.005512, "average": 0.981696, "min": 0.534377}, "location": {"width": 738, "top": 1003, "height": 26, "left": 244}, "words": "有活动性感染、消化道溃疡和溃疡性结肠炎存在时,甲氨蝶呤的使用要非常慎重。甲氨"}, {"probability": {"variance": 0.00468, "average": 0.976178, "min": 0.574891}, "location": {"width": 774, "top": 1033, "height": 27, "left": 209}, "words": "蝶呤有免疫抑制活性,可能导致严重的甚至致死性的感染。在兔疫反应对患者可能是非常重"}, {"probability": {"variance": 0.016927, "average": 0.932084, "min": 0.482575}, "location": {"width": 458, "top": 1064, "height": 24, "left": 205}, "words": "要或必要时,评估甲氨蝶呤的使用必须要考虑该因素"}, {"probability": {"variance": 0.012878, "average": 0.936647, "min": 0.620358}, "location": {"width": 737, "top": 1094, "height": 25, "left": 245}, "words": "可能发生肺炎(些情况会导致呼吸衰竭)。在甲氨蝶呤治疗中可能会发生潜在致死性"}, {"probability": {"variance": 0.014121, "average": 0.956095, "min": 0.404801}, "location": {"width": 776, "top": 1123, "height": 30, "left": 206}, "words": "的机会性感染,特别是卡氏脏囊虫性肺炎。患若现肺部症状时,应考虑卡氏肺囊虫性肺炎"}, {"probability": {"variance": 1e-06, "average": 0.998787, "min": 0.997094}, "location": {"width": 83, "top": 1157, "height": 24, "left": 206}, "words": "的可能性"}, {"probability": {"variance": 0.007497, "average": 0.947981, "min": 0.594162}, "location": {"width": 549, "top": 1187, "height": 25, "left": 247}, "words": "明显的或实验室检证实的免疫缺陷思者通常禁止使用甲氨蝶呤"}, {"probability": {"variance": 0.022333, "average": 0.938757, "min": 0.371117}, "location": {"width": 736, "top": 1219, "height": 27, "left": 247}, "words": "甲氨蝶呤治疗期间行免疫接种可能是无效的一般不推荐接种活病疫苗。曾报道患者"}, {"probability": {"variance": 0.011838, "average": 0.952806, "min": 0.533543}, "location": {"width": 459, "top": 1250, "height": 25, "left": 245}, "words": "在甲氨蝶呤治疗期间接种大花疫前后发生播散性感染"}, {"probability": {"variance": 2e-06, "average": 0.99808, "min": 0.99429}, "location": {"width": 204, "top": 1310, "height": 26, "left": 206}, "words": "驾驶或操作机械的能力"}, {"probability": {"variance": 0.012044, "average": 0.954131, "min": 0.545159}, "location": {"width": 592, "top": 1343, "height": 26, "left": 252}, "words": "甲氨蝶呤的不良反应,如头晕和疲劳可以影响驾驶或操作机械的能力"}, {"probability": {"variance": 1.4e-05, "average": 0.997271, "min": 0.989177}, "location": {"width": 124, "top": 1406, "height": 27, "left": 206}, "words": "操作注意事项"}, {"probability": {"variance": 0, "average": 0.845686, "min": 0.845686}, "location": {"width": 31, "top": 1404, "height": 34, "left": 678}, "words": "介"}, {"probability": {"variance": 0, "average": 0.984639, "min": 0.984639}, "location": {"width": 33, "top": 1392, "height": 35, "left": 713}, "words": "司"}, {"probability": {"variance": 0.00405, "average": 0.976769, "min": 0.678958}, "location": {"width": 730, "top": 1438, "height": 29, "left": 253}, "words": "与所有抗肿瘤药物相同,配制甲氨蝶岭注射液必须受过训练的专业人员在指定地点"}, {"probability": {"variance": 0.003175, "average": 0.974576, "min": 0.709921}, "location": {"width": 776, "top": 1468, "height": 28, "left": 206}, "words": "完成(最好在细胞毒性层流中)。在操作过程中应感防护手套果皮肤或粘膜意外接触甲"}, {"probability": {"variance": 0.017269, "average": 0.912934, "min": 0.532023}, "location": {"width": 646, "top": 1492, "height": 38, "left": 205}, "words": "氨蝶呤溶液.污染部位应立即用肥皂和清水彻底清洗一"}, {"probability": {"variance": 0.010426, "average": 0.959193, "min": 0.57958}, "location": {"width": 407, "top": 1529, "height": 26, "left": 249}, "words": "建议怀孕妇女不要接触细胞球药物例如甲氨蝶"}, {"probability": {"variance": 0.024731, "average": 0.907399, "min": 0.448116}, "location": {"width": 717, "top": 1554, "height": 35, "left": 257}, "words": "建议使用配有Ler一lock的注射器,建议使川火孔修头以减小压力,避免形成气雾"}], "language": 3}